REFERENCES
1. Radzinsky V.E., Khamoshina M.B. Unsolved problems of modern gynecology: Quo vadis? Doctor.Ru. 2016; 7 (124): 4-9. (in Russian)
2. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Temporary Methodological recommendations of the Ministry of Health of the Russian Federation. Version 13 (14.10.2021). 2021: 6. (in Russian)
3. Yunusova D.Z. Maternal losses during the COVID-19 pandemic in Tajikistan. In: Ott Readings: Abstracts III All-Russian Scientific and Practical Conferences for Obstetricians and Gynecologists (12-13 November 2021, St Petersburg). Moscow: Izdatel’stvo zhurnala StatusPraesens, 2021: 36. (in Russian)
4. World Health Organization (WHO) Weekly Operational Update on COVID-19 // Emergency Situational Updates. 2021. Vol. 77. P. 1-10.
5. Belokrinitskaya T.E., et al. Clinical course, maternal and neonatal outcomes of COVID-19 infection in pregnancy: an epidemiological study in Siberia and the Far East. Gynecology. 2021; 23 (1): 43-7.
6. Sacinti K.G., et al. Increased incidence of first-trimester miscarriage during the COVID-19 pandemic. Ultrasound Obstet Gynecol. 2021; 57 (6): 1013-4.
7. Methodological recommendations of the Ministry of Health of the Russian Federation «Organization of medical care for pregnant women, women in labor, maternity women and newborns with a new coranovirus infection COVID-19». 2021. Version 4: 6. (in Russian)
8. RANZCOG. COVID-19 Vaccination in Pregnant and Breastfeeding Women. Updated Wednesday 10 March 2021. URL: https://ranzcog.edu.au/statementsguide-lines/covid-19-statement/covid-19-vaccination-information
9. URL: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/effectiveness.html
10. States U. When will the COVID-19 pandemic end? March 2021 Update.
11. Khamoshina M.B., Demina O.A., Ismailova A., Artemenko Y.S., Ramaza-nova F.U. Abstracts of the III All-Russian Scientific and Practical Conference for obstetrician-gynecologists "Otto Readings" (November 12-13, 2021, St. Petersburg). Moscow: Publishing House of Status Praesens, 2021. 32 p. (in Russian)
12. Diamond-Smith N., et al. COVID-19’s impact on contraception experiences: exacerbation of structural inequities in women’s health. Contraception. 2021; 104 (6): 600-5.
13. Carneiro Gomes P.R., et al. Alterations of the male and female reproductive systems induced by COVID-19. Wien Klin Wochenschr. 2021; 133 (17-18): 966-72.
14. Sharma I., et al. SARS-CoV-2 and the reproductive system: known and the unknown..!! Middle East Fertil Soc J. 2021; 26 (1): 1.
15. Hoffmann M., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181 (2): 271-80.e8.
16. Wang M.Y., et al. SARS-CoV-2: structure, biology, and structure-based therapeutics development. Front Cell Infect Microbiol. 2020; 10: 587269.
17. Dong M., et al. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed Pharmacother. 2020; 131: 110678.
18. Cui D., et al. Single-cell RNA expression profiling of SARS-CoV-2-related ACE2 and TMPRSS2 in human trophectoderm and placenta. Ultrasound Obstet Gynecol. 2021; 57 (2): 248-56.
19. Weatherbee B.A.T., Glover D.M., Zernicka-Goetz M. Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester. Open Biol. 2020; 10 (8): 200162.
20. Liu H., et al. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company’s public news and information website. 2020. January.
21. Zambrano L.D., et al. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status -United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69 (44): 1641-7.
22. Collin J., et al. Public Health Agency of Sweden’s Brief Report. Pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden. Acta Obstet Gynecol Scand. 2020; 99 (7): 819-22.
23. Narang K., et al. SARS-CoV-2 Infection and COVID-19 during pregnancy: a multidisciplinary review. Mayo Clin Proc. 2020; 95 (8): 1750-65.
24. Bloise E., et al. Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm. Am J Obstet Gynecol. 2021; 224 (3): 298.e1-8.
25. Sills E.S., Wood S.H. An experimental model for peri-conceptual COVID-19 pregnancy loss and proposed interventions to optimize outcomes. Int J Mol Cell Med. 2020; 9 (3): 180-7.
26. Tishkova O.G., Dikareva L.V. The role of the growth factor of differentiation (CDF-15) in the genesis of miscarriage. In: Ott Readings: Abstracts III All-Russian Scientific and Practical Conferences for Obstetricians and Gynecologists (12-13 November 2021, St Petersburg). - Moscow: Izdatel’stvo zhurnala StatusPraesens, 2021: 30-1. (in Russian)
27. Sharps M.C., et al. A structured review of placental morphology and histopathological lesions associated with SARS-CoV-2 infection. Placenta. 2020; 101: 13-29.
28. Baergen R.N., Heller D.S. Placental pathology in COVID-19 positive mothers: preliminary findings. Pediatr Dev Pathol. 2020; 23 (3): 177-80.
29. Markelova E.V., Tulupova M.S., Khamoshina M.B., Chepurnova N.S., Nevezhkina T.A. The role of the male factor in miscarriage. Problemy reproduktsii [Problems of Reproduction]. 2020; 26 (4): 85-90. (in Russian)
30. Agnaeva A.O. Assessment of the role of NK cells in the pathogenesis of multiple early reproductive losses: Diss. Saint Petersburg, 2019: 24 p. (in Russian)
31. Miscarriage (spontaneous abortion). Clinical guidelines of the Ministry of Health of the Russian Federation. 2021. URL: https://cr.minzdrav.gov.ru/recomend/670_1 (in Russian)
32. Favre G., et al. 2019-nCoV epidemic: what about pregnancies? Lancet. 2020; 395 (10 224): e40.
33. Yan J., et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. Am J Obstet Gynecol. 2020; 223 (1): 111.e1-14.
34. Chen L., et al. Clinical characteristics of pregnant women with COVID-19 in Wuhan, China. N Engl J Med. 2020; 382 (25): e100.
35. Curi B., et al. Coronavirus infection in a high-risk obstetrical population of the South Bronx, New York. Am J Obstet Gynecol MFM. 2020; 2 (4): 100203.
36. D’Antonio F., et al. Maternal and perinatal outcomes in high compared to low risk pregnancies complicated by severe acute respiratory syndrome coronavirus 2 infection (phase 2): the World Association of Perinatal Medicine working group on coronavirus disease 2019. Am J Obstet Gynecol MFM. 2021; 3 (4): 100329.
37. Jing Y., et al. Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod. 2020; 26 (6): 367-73.
38. Knight M., et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020; 369: m2107.
39. Shmakov R.G., et al. Clinical course of novel COVID-19 infection in pregnant women. J Matern Fetal Neonatal Med. 2020; Nov 29: 1-7.
40. Kazemi S.N., et al. COVID-19 and cause of pregnancy loss during the pandemic: A systematic review. PLoS One. 2021; 16 (8): e0255994.
41. Cavalcante M.B., et al. COVID-19 and miscarriage: from immunopathological mechanisms to actual clinical evidence. J Reprod Immunol. 2021; 148: 103382.
42. Pereira M., Dantas Damascena A., Galvao Azevedo L.M., de Almeida Oliveira T., da Mota Santana J. Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2020; Nov 4: 1-9. DOI: https://doi.org/10.1080/10408398.2020.1841090